Aly Karsan
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- NF-κB Signaling Pathways
- Immunology top 1%
- Immune Response and Inflammation
Papers in
- Hematology 52
- Acute Myeloid Leukemia Research 38
-
- Cancer Genomics and Diagnostics 32
- NF-κB Signaling Pathways 16
- Co-authors
- Kevin G. LeongKyle NiessenJohn M. HarlanShauna DauphineeEsther YeeFred WongLinda ChangMichela Noseda
- Journals
- Blood (22 papers)Journal of Biological Chemistry (9 papers)Journal of Molecular Diagnostics (9 papers)Experimental Hematology (5 papers)The Journal of Immunology (5 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Aly Karsan
192 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.4k
- Immunology 2.1k
- Hematology 1.1k
- Molecular Biology 5.6k
- Immunology and Allergy 466
Countries citing papers authored by Aly Karsan
This map shows the geographic impact of Aly Karsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly Karsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly Karsan more than expected).
Fields of papers citing papers by Aly Karsan
This network shows the impact of papers produced by Aly Karsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly Karsan. The network helps show where Aly Karsan may publish in the future.
Co-authors
The 25 scholars most cited alongside Aly Karsan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 25 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 39 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 41 | |
| 14 | 2020 | 31 | |
| 15 | 2020 | 31 | |
| 16 | 2020 | 1 | |
| 17 | 2019 | 6 | |
| 18 | 2014 | 29 | |
| 19 | 2012 | 61 | |
| 20 | 2010 | 94 |
About Aly Karsan
Aly Karsan is a scholar working on Hematology, Cancer Research, Immunology, Genetics and Immunology and Allergy, having authored 202 papers that have together received 9.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (38 papers), Cancer Genomics and Diagnostics (32 papers), Angiogenesis and VEGF in Cancer (21 papers), Lung Cancer Treatments and Mutations (17 papers), Lymphoma Diagnosis and Treatment (16 papers), NF-κB Signaling Pathways (16 papers), Immune Response and Inflammation (16 papers) and Cell death mechanisms and regulation (15 papers). The work is most often cited by research in Cancer Research (2.4k citations), Immunology (2.1k citations), Hematology (1.1k citations), Molecular Biology (5.6k citations) and Immunology and Allergy (466 citations). Aly Karsan has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Kevin G. Leong, Kyle Niessen, John M. Harlan, Shauna Dauphinee, Esther Yee, Fred Wong, Linda Chang, Michela Noseda, Thomas Bombeli and Jonathan F. Tait. Their work appears in journals such as Blood, Journal of Biological Chemistry, Journal of Molecular Diagnostics, Experimental Hematology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.